Oral semaglutide offers convenience for needle-averse patients but requires specific timing on an empty stomach and carries lower bioavailability than injections
Combining PlexusDx genetic insights with baseline kidney function, hydration assessment, and protein intake monitoring creates a personalized framework for safe creatine use during GLP-1 therapy
For programmes costing 500, and 1000, an average additional weight loss of 2, and 3 kg, respectively, must be maintained for life
Wegovy, Zepbound, and Foundayo, however, are designed for managing weight specifically
However, Semaglutide is most effective when coupled with routine exercise and a healthy diet
It slows the rate at which food leaves the stomach, which may help patients feel full sooner and remain satisfied longer